GKOS NYSE Week ended 31 Jul 2026

Weekly Investor Report

Glaukos Corp · Healthcare · Medical Devices

Latest close 166.7 USD
8.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 32.8% above the Trend Line and sits at 84.4% of its 52-week range. The latest completed week returned 8.6%, after a 12.4% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers. Options positioning is volatility with 51/100 conviction, while the latest news-sentiment score is 62/100.

Setup score 71 out of 100
Latest Close 166.7 USD 31 Jul 2026
1W Return 8.6% latest completed week
4W Return 12.4% short-term follow-through
12W Return 24.9% quarterly tape
Trend Breadth 63.5% 33 of 52 weeks active
Volume Ratio 1.8x vs 13-week average
What is working
  • The trend backdrop is active with a 33-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 9 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 32.8% above the Trend Line and sits at 84.4% of its 52-week range. The latest completed week returned 8.6%, after a 12.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8112-week average 0.66

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.81Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers99 reversal markers

No recent accumulation markers. 9 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 12.4% over four weeks, 24.9% over 12 weeks, and 93.5% over one year. The current trend has remained active for 33 consecutive weeks.

Performance by holding period

1W8.6%
4W12.4%
12W24.9%
26W39.7%
52W93.5%
Active trend streak33 weeks
Active weeks in one year33
Trend breadth63.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.32Latest activity-pressure read.
Pressure change87.1%Four-week change in activity pressure.
Leadership37.60Latest relative-leadership reading.
RS change43.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth ranks strongly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength15/100Blend of value, momentum, and quality. Underlying universe rank 86; rank 1 is best.
Value13/100Relative valuation strength. Underlying universe rank 88; rank 1 is best.
Quality13/100Profitability and accounting quality. Underlying universe rank 88; rank 1 is best.
Momentum89/100Medium-term price momentum. Underlying universe rank 12; rank 1 is best.
Growth84/100Revenue and earnings growth. Underlying universe rank 17; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
16.4x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
0.0%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
78.1%
Gross profit retained from each unit of revenue.
Operating margin
-34.4%
Operating profit retained from revenue.
Free-cash-flow margin
0.2%
Free cash flow generated from revenue.
Return on invested capital
-21.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
36.3%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.4%
Net share repurchases relative to market value.
Shareholder yield
-0.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

GKOS shows volatility options pressure with a 51/100 conviction score, put-call volume ratio of 25.68, expected move of 9.6%, and Sharemaestro trend signal active.

Conviction51/100
Expected move9.6%
Put/call volume25.68
Pressure-100
Speculation10
Volatility74
Trend agreement0
Open options detail
Insider activity9 / 11

9 acquisitions and 11 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment62/100

Weighted news tone is positive across 70 relevant articles.

32 positive · 35 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings29 JulLatest stored earnings date was 29 Jul 2026.
Options expected move9.6%Nearest-chain priced movement where available.
52-week drawdown-9.4%Distance below the 52-week high.
13-week volatility9.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+20.9%Week of 5 Jun.
Worst week-16.5%Week of 22 May.
Latest week+8.6%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains8
Flat weeks0
Modest losses3
Sharp losses6
Recent vol9.5%13-week weekly-return volatility.
Base vol7.7%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew6.3% / -5.9%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 2026166.7 USD8.6%125.5 USD107.4 USD1.3237.608.6MOn
24 Jul 2026153.6 USD-2.1%123.7 USD106.8 USD1.0729.422.3MOn
17 Jul 2026156.8 USD2.7%122.4 USD106.4 USD1.0832.302.7MOn
10 Jul 2026152.7 USD3.0%121.1 USD105.8 USD0.8927.673.9MOn
3 Jul 2026148.3 USD2.7%119.6 USD105.4 USD0.7026.224.3MOn
26 Jun 2026144.4 USD10.5%118.3 USD104.8 USD0.5826.044.9MOn
19 Jun 2026130.7 USD3.1%117.0 USD104.4 USD0.3311.773.6MOn
12 Jun 2026126.8 USD1.4%116.0 USD104.0 USD0.419.534.9MOn
5 Jun 2026125.0 USD20.9%114.7 USD103.6 USD0.578.657.4MOn
29 May 2026103.3 USD-14.0%113.4 USD103.2 USD0.59-12.287.2MOn
22 May 2026120.2 USD-16.5%112.9 USD103.0 USD0.893.216.5MOn
15 May 2026144.0 USD7.9%111.3 USD102.5 USD0.6524.613.5MOn
8 May 2026133.5 USD-4.8%109.5 USD102.0 USD0.3616.243.7MOn
1 May 2026140.2 USD15.4%107.8 USD101.5 USD0.1325.256.5MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.